Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma

被引:72
|
作者
Mullerad, M
Russo, P
Golijanin, D
Chen, HN
Tsai, HH
Donat, SM
Bochner, BH
Herr, HW
Sheinfeld, J
Sogani, PC
Kattan, MW
Dalbagni, G
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Radiol, HNC, New York, NY 10021 USA
来源
JOURNAL OF UROLOGY | 2004年 / 172卷 / 06期
关键词
carcinoma; transitional cell; bladder; urinary tract; prognosis;
D O I
10.1097/01.ju.0000144505.40915.98
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Upper tract transitional cell carcinoma (UTTCC) is a relatively rare tumor. Overall 5-year disease specific survival is in the range of 16.5% to 95% depending on stage. In this study we evaluated predictors associated with disease recurrence and disease specific survival. Materials and Methods: We report on 129 patients with a median age of 68 years who underwent nephroureterectomy for UTTCC between July 1989 and June 2002. A total of 67 patients had primary UTTCC and 62 had previous (52) or synchronous (10) transitional cell carcinoma of the bladder (BTCC). Medical records were reviewed and analyzed for possible prognostic predictors (primary tumor stage, grade, multifocality, carcinoma in situ, symptoms and signs at presentation, sex, and history of smoking). Disease specific survival and freedom from bladder recurrence were assessed with the Kaplan-Meier method, and differences between the groups were compared using the log rank test. The Cox proportional hazards regression model was used to assess the significance of each predictor. Results: Disease specific death was reported for 44 patients. In a multivariate analysis using previous BTCC as a predictor (categorized as superficial, invasive or none), primary disease stage and history of BTCC were associated with disease specific survival (p = 0.001 and p = 0.018). History of BTCC grouped the patients into distinct populations in terms of disease specific survival and freedom from bladder recurrence. Conclusions: This study demonstrates that a history of BTCC (invasive or superficial) has an adverse effect on the prognosis of patients diagnosed with UTTCC independent of primary tumor stage.
引用
收藏
页码:2177 / 2181
页数:5
相关论文
共 50 条
  • [1] Previous history of bladder cancer is an independent prognostic factor for upper tract transitional cell carcinoma
    Kikuchi, Eiji
    Miyajima, Akira
    Nakagawa, Ken
    Oya, Mototsugu
    Ohigashi, Takashi
    Nakashima, Jun
    Murai, Masaru
    [J]. JOURNAL OF UROLOGY, 2007, 177 (04): : 135 - 135
  • [2] Previous history of bladder cancer as a prognostic factor for patients diagnosed with transitional cell carcinoma of the upper urinary tract.
    Mullerad, M
    Golijanin, D
    Chen, HN
    Donat, S
    Bochner, B
    Herr, HW
    Sogani, PC
    Russo, P
    Kattan, MW
    Dalbagni, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 406S - 406S
  • [3] Upper tract transitional cell carcinoma following cystectomy for bladder cancer
    Huguet-Pérez, J
    Palou, J
    Millán-Rodríguez, F
    Salvador-Bayarri, J
    Villavicencio-Mavrich, H
    Vicente-Rodríguez, J
    [J]. EUROPEAN UROLOGY, 2001, 40 (03) : 318 - 323
  • [4] Prognostic factors for survival and bladder recurrence in transitional cell carcinoma of the upper urinary tract
    Morioka, M
    Jo, Y
    Furukawa, Y
    Kinugawa, K
    Sone, A
    Matsuki, T
    Kobayashi, T
    Fujii, T
    Tanaka, H
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2001, 8 (07) : 366 - 373
  • [5] Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma
    Akdogan, Bulent
    Dogan, Hasan Serkan
    Eskicorapci, Saadettin Yilmaz
    Sahin, Ahmet
    Erkan, Ilhan
    Ozen, Haluk
    [J]. JOURNAL OF UROLOGY, 2006, 176 (01): : 48 - 52
  • [6] A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract
    Stewart, GD
    Bariol, SV
    Grigor, KM
    Tolley, DA
    McNeill, SA
    [J]. BJU INTERNATIONAL, 2005, 95 (06) : 791 - 793
  • [7] Metallothionein expression as prognostic factor for transitional cell carcinoma of bladder
    Yamasaki, Y
    Smith, C
    Weisz, D
    van Huizen, I
    Xuan, J
    Moussa, M
    Stitt, L
    Hideki, S
    Cherian, MG
    Izawa, JI
    [J]. UROLOGY, 2006, 67 (03) : 530 - 535
  • [8] Prognostic factors of primary transitional cell carcinoma of the upper urinary tract
    Lee, SH
    Lin, JSN
    Tzai, TS
    Chow, NH
    Tong, YC
    Yang, WH
    Chang, CC
    Cheng, HL
    [J]. EUROPEAN UROLOGY, 1996, 29 (03) : 266 - 270
  • [9] Risk factors for the development of bladder transitional cell carcinoma following surgery for transitional cell carcinoma of the upper urinary tract
    Koga, F
    Nagamatsu, H
    Ishimaru, H
    Mizuo, T
    Yoshida, K
    [J]. UROLOGIA INTERNATIONALIS, 2001, 67 (02) : 135 - 141
  • [10] Independent predictors of metachronous bladder transitional cell carcinoma after nephroureterectomy for transitional cell carcinoma of the upper urinary tract
    Novara, G.
    De Marco, V.
    Dalpiaz, O.
    Bouygues, V.
    Galfano, A.
    Martignoni, G.
    Patand, J. J.
    Artibani, W.
    Ficarra, V.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 136 - 136